The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

Marc Cohn has taken took Instagram to reveal his hope amid his Parkinson’s disease diagnosis.

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

Treatment with exenatide, a GLP-1 receptor agonist, was comparable to placebo in slowing the rate of Parkinson’s disease ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

Richard Balanson says when one suffers a disease "you begin to accumulate friends" who have their own story with the same ...

All aboard the "Crazy Train" — Black Sabbath will be reuniting for a performance in Ozzy Osbourne's hometown of Birmingham, U ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...

Lewy body diseases (LBDs) are a class of debilitating neurodegenerative disorders linked to the abnormal aggregation of the ...

The number of diagnosed cases is expected to rise to 3.1 million. The Parkinson’s disease (PD) market across the seven major ...